Immunotherapy has transformed treatment for patients with stage 4 metastatic esophageal and gastric cancers. In patients with these malignancies, immunotherapy has been shown to prolong survival when patients' tumors exhibit a high expression of an immune-related protein called PD-L1.
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Mayo Clinic Cancer Center in Phoenix developed and implemented a new system that allows chemotherapy infusions to be scheduled throughout the day.The initiative — described in a paper published in JCO Oncology Practice — prevents mid-day crowding in infusion facilities.